For storage best practices, see how to store peptides
Evidence suggests that patients exhibit better responses to GLP-1 therapy when doses are adjusted based on their specific metabolic responses, further underscoring the importance of personalized dosing
Its really difficult for these patients to lose weight, but it can provide a cure. According to Falardeau, research has shown that a 6% to 10% reduction of body weight can help patients achieve remission, with GLP-1 receptor agonists showing fantastic results in patients with non-vision-threatening IIH
Gastrointestinal effects dominate: nausea (2044% of users), vomiting (1025%), diarrhea (1520%), and constipation (1015%)
Saxenda helps people feel fuller and reduces their appetite, making it easier to manage weight